The clinical class of CLL is very heterogeneous, starting from a reasonably asymptomatic condition which could even regress spontaneously into a progressive disease that finally causes the patient’s Demise, so there has often been amazing fascination in deciding the prognosis of specific clients. Even though lots of prognostic markers are determi